您当前的位置：
首页 >
文章列表页 >
Application and clinical research progress of FGFR inhibitors in the treatment of malignant tumors
Review | 更新时间：2026-10-28

    • Application and clinical research progress of FGFR inhibitors in the treatment of malignant tumors

    • Chin J Hosp Pharm   Vol. 46, Issue 17, Pages: 2065-2073(2026)

    • DOI：10.13286/j.1001-5213.2026.17.14    

      CLC： R979.1

    • Published：15 September 2026

    移动端阅览

  • WANG Yixuan,LIN Mengmeng,HAN Yijia,et al.Application and clinical research progress of FGFR inhibitors in the treatment of malignant tumors[J].Chin J Hosp Pharm,2026,46(17):2065-2073. DOI： 10.13286/j.1001-5213.2026.17.14.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Systematic review of the safety of immune rechallenge after immune-related hepatitis
Network Meta-analysis of novel oral factor Ⅹa inhibitors for the treatment of pulmonary embolism in middle-aged and older adults
Evaluation of the efficacy and adverse reactions of original-brand and centralized procurement formulations voriconazole in critically ill patients based on therapeutic drug monitoring
Evaluation of the hemostatic effect of microporous starch composite hemostatic powder
Efficacy and safety of national centralized procurement cefuroxime for perioperative prophylaxis in orthopedic surgery： a multicenter real-world study

Related Author

LI Rongjie
HUANGFU Rui
HOU Kun
CHEN Yuan
LAN Hua
PING Yaodong
LI Qinghuan
LI Haifeng

Related Institution

School of Pharmacy， Inner Mongolia Medical University
Department of Pharmacy， Peking University Cancer Hospital Inner Mongolia Hospital
Key Laboratory of Carcinogenesis and Translational Research， Department of Pharmacy， Peking University Cancer Hospital & Institute
a. Department of Pharmacy， 1b. Department of Respiratory and Critical Care Medicine， the Third People’s Hospital of Yunnan Province，Yunnan Kunming650011， China； 2.College of Pharmacy， Dali University， Yunnan Dali
云南省第三人民医院，呼吸与危重症医学科
0